Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL (Q71177249)
scientific article published on 01 May 1996
Language:
Current Data About Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL
(P31) (Q13442814)
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P304) 1432-1438
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P407) (Q1860)

(P433) 9013
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P478) 347
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P577) Wednesday, May 1, 1996
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P921) (Q6934595)
(P887)

(Q18936)
(P887)

(P1433) (Q939416)
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P1476) "Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL" (language: en)
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P2093) S Johnson
(P1545) 1
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

A G Smith
(P1545) 2
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

H Löffler
(P1545) 3
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

E Osby
(P1545) 4
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

G Juliusson
(P1545) 5
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

B Emmerich
(P1545) 6
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

P J Wyld
(P1545) 7
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

W Hiddemann
(P1545) 8
(P248)
(P698) 8676625
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8676625%20AND%20SRC:MED&resulttype=core&format=json
(P813) Wednesday, October 16, 2019

(P2860) (Q34282319)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q69736425)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q33457996)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q53753726)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q88009928)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q88009927)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q33492158)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q72884028)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q87999243)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q41262857)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q72229161)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q41137537)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q72555968)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

(Q40394311)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2991681-5
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on 01 May 1996

External Links
(P356) 10.1016/S0140-6736(96)91681-5
(P698) 8676625